Prefilled Syringes Market - SITE LICENSE

Prefilled syringes have currently emerged as one of the fastest growing choices for unit dose medication since the pharmaceutical industry attempts to explore modern and more convenient drug delivery methods for application. With the evolution of prefilled syringes, pharmaceutical companies are able to efficiently minimize the drug waste and increase product life span, while the patients are able to self-administer injectable drugs at their homes instead of hospitals. Prefilled syringes represent one of the fastest emergent segment among the injectable drug delivery devices market. The primarily factors associated with the use of prefilled syringes are ease of administration, condensed risk of cross contamination, a reduced amount of overfill and ease of treatment.

This research study includes an extensive analysis of the prefilled syringes market, by product type, material, design and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. The two major segments described in the study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size and market volume, considering the macro and micro environmental factors.
The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key market participants. While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section on competitive landscape, market share analysis, competitive benchmarking, and the position of competitors within the global prefilled syringe market.
The following key questions have been addressed in the report:
What are the major market drivers, challenges and opportunities of the global prefilled syringes market?
How is the prefilled syringes market evolving during the forecast period?
What are the driving and restraining factors in the prefilled syringes market?
What are the market shares of the leading segments and sub-segments of the global prefilled syringes market in 2016 and 2023?
How will each segment of the prefilled syringes market grow over the forecast period and how much revenue will these account for in 2023?
How will the market share of the leading companies change in 2017 and which country will lead the market in 2017?
How will the industry evolve during the period between 2017 and 2023?
What are the key developmental strategies implemented in different types across all regions?
Which geographical region will lead the global prefilled syringes market by the end of the forecast period?
What are the market trends and key developments in this market?
The report includes the profiles of major players in the market that allows the readers to get an insight into the various industry trends. Some of the leading companies in the market are Gerresheimer AG, Schott AG, Stevanato Group, Baxter International, Inc., Unilife Corporation, Terumo Corporation, West Pharmaceuticals, Inc., Vetter pharmaceuticals and Becton Dickinson and Co.
Executive Summary
1 Research Scope and Methodology
1.1 Scope of the Report
1.2 Global GERD Therapy Market Segmentation
1.3 Key Objectives
1.4 Research Methodology
1.4.1 Data Triangulation
1.4.2 Secondary Sources
1.4.3 Primary Sources
1.4.4 Top-Down Approach
1.4.5 Bottom-Up Approach
1.4.6 Assumptions and Limitations
1.4.7 Data and Prediction Modelling
2 Market Overview
2.1 Introduction
2.2 Advantages of Prefilled Syringes over traditional vial & syringe system
2.3 Manufacturing & Packaging Challenges of Prefilled Syringes
2.4 Benefits of prefilled syringes to the drug makers
2.5 Technology Trends in Market
2.6 Legal Requirements and Regulations
2.7 Patent Analysis
3 Market Dynamics
3.1 Drivers
3.2 Challenges
3.. Opportunities
4 Competitive Landscape
4.1 Key Market Development and Strategies
4.1.1 Mergers and Acquisition
4.1.2 Product Launch & Developments
4.1.3 Partnerships, Collaborations & Joint Ventures
4.1.4 Business Expansions and Contracts
4.2 Market Share Analysis
4.3 Industry Attractiveness
5 Industry Analysis
5.1 Regulatory Bodies and Associations
5.2 Patent Landscape
6 Global Prefilled Syringes by Type, 2016-2023 (Qualitative)
6.1 Overview
6.2 Conventional Prefilled Syringes
6.3 Safety Prefilled Syringes
7 Global Prefilled Syringes by Design, 2016-2023 (Qualitative)
7.1 Overview
7.2 Single-Chamber Prefilled Syringes
7.3 Dual-Chamber Prefilled Syringes
7.4 Customized Prefilled Syringes
8 Global Prefilled Syringes by Material Revenue ($Million) and Volume (Million Units), 2016-2023
8.1 Overview
8.2 Glass Prefilled Syringes
8.3 Plastic Prefilled Syringes
9 Global Prefilled Syringes Market by Region, Revenue ($Million) and Volume (Million Units), 2016-2023
9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia Pacific (APAC)
9.5 Rest of the World (RoW)
10 Company Profiles
10.1 Baxter International
10.2 Becton Dickinson & Company
10.3 Bristol Myers Squibb
10.4 Eli Lilly
10.5 Gerresheimer
10.6 Medtronic Inc.
10.7 Nipro Corporation
10.8 Pfizer
10.9 SCHOTT AG
10.1 Stevanto Group
10.11 Terumo Corporation
10.12 Unilife Corporation
10.13 Vetter Pharmaceuticals GmBH
10.14 Weigao Group
10.15 West Pharmaceutical Services
10.16 Snapshot of Other Key Players
Prefilled syringes are increasingly witnessed as a primary choice for most of the high-end injectable drugs due to various advantages they offer over traditional packaging systems. A prefilled syringe is a single dose primary sterile container and delivery system that is filled aseptically with an injectable drug and sold for parenteral administration of drugs to patients. Anticoagulants, antivirals, anaphylaxis, hematopoietic, monoclonal antibodies and vaccines are the most commonly used therapeutic categories in the prefilled syringe format. Nowadays, with the help of prefilled syringes, pharmaceutical companies are able to minimize the drug waste and increase product life span, while the patients are able to self-administer injectable drugs at their home instead of the hospitals.
Despite the high paced competition in the global prefilled syringes market, future prospective growth is expected to be driven by favorable factors such as accurate drug dosing, negligible overfill requirements, no preservatives required in the formulation, increased assurance of sterility, ease of use and handling, time saving in emergency situations, and reduced material cost, among others, which are some of the major advantages provided by prefilled syringes. As a result, prefilled syringes represent one of the fastest growing segments among the injectable drug delivery devices market.
The prefilled syringes market is growing exponentially worldwide due to the increase in prevalence of chronic diseases, growing demand and higher production of large molecule biologics and biosimilars, high penetration rate of self-injection devices and continuous advancement in prefilled syringes with the inclusion of autonomous inbuilt safety mechanisms. The global prefilled syringes market has been segmented into four major regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW).The European and North American markets are dominant in terms of market share, which is attributed to the presence of leading prefilled syringes and biological drug manufacturing players in both the regions.
Syringe manufacturers provide prefillable syringes in pre-sterilized or bulk forms to drug manufacturers for filling of various categories of injectable drugs including anticoagulants, vaccines, antivirals, hematopoietics, monoclonal antibodies and some other emergency drugs. The global market for prefilled syringes is expected to grow at a CAGR of 10.75% from 2017 to 2021, to reach a value of $XX million in 2021. In terms of volume, the market for prefilled syringes is anticipated to reach 8320.6 million units in 2021, growing at a CAGR of 12.31% during the forecast period 2017 to 2021.
Europe dominated the global market in 2016 with a share of XX%. Its market size by volume was estimated to be XX million units in 2016 and is projected to reach XX million units by 2021, registering a CAGR of XX% between 2017 and 2021. However, the Asia Pacific is estimated to show highest growth with a CAGR of XX% from 2017 to 2021.
The global glass prefilled syringe market value is accounted to be $XX million in 2016 and is projected to reach $XX million by 2021, registering a CAGR of XX % between 2017 and 2021.
The increasing demand for safety plastic prefilled syringes due to its convenience and cost effectiveness have obligated companies to focus on new product developments and innovations. The most prominent opportunity for the industry players is market penetration in emerging markets such as Japan, China, Australia and India. Currently, the market is dominated by Europe due to the presence of established prefilled syringe and biological drug manufacturers based in Europe. However, stringent regulatory standards regarding combination products and high manufacturing cost of prefilled syringes are hampering the growth of the market. Market penetration, establishment and outreach of major key players in the emerging markets, and increasing biologics and bio-similar in the market will serve as viable opportunities for the market players to enhance their business in the future.
The key players are Gerresheimer AG, Schott AG, Stevanato Group, Baxter International, Inc., Unilife Corporation, Terumo Corporation, West Pharmaceuticals, Inc., Vetter pharmaceuticals and Becton Dickinson and Co, among others.
North America
Europe
APAC
RoW
Market Research, market research reports, market report, market forecast, market outlook, market analysis, market size, market study, market growth, market trends, market estimates, market survey, industry report, Technology Report, market overview, market share, emerging technology market, emerging technology market research, emerging technology market intelligence
Prefilled syringes are increasingly witnessed as a primary choice for most of the high-end injectable drugs due to various advantages they offer over traditional packaging systems. Anticoagulants, antivirals, anaphylaxis, hematopoietic, monoclonal antibodies and vaccines are the most commonly used therapeutic categories in the prefilled syringe format. Nowadays, with the help of prefilled syringes, pharmaceutical companies are able to minimize the drug waste and increase product life span, while the patients are able to self-administer injectable drugs at their home instead of the hospitals.
Heparins and Vaccine are biological preparation which are mainly used in prefilled syringes, accounting for approximately 75% of the prefilled syringes application market. There has been profound advancement in the development of novel biological drugs and syringe safety mechanism technologies that is spurring the market growth at an exponential rate. More than 60% of the biologics which are being manufactured are of large molecules and expensive. These biologics need to be administered intravenously in a prefilled syringe to prevent wastage due to overfill as is done in conventional vial and syringe system. At present, owing to the rigorous research and development activities along with positive outcomes at clinical trials, market players operating in the prefilled syringes market have been successful in developing prefilled syringes with safety needle retraction features in order to address the growing needle stick injuries among the healthcare workers and patients.
The major factors contributing to the growth of prefilled syringes market are: growing elderly population, rising incidence and prevalence rates of chronic disease, rise in demand for self-administration mechanisms (syringes and auto injectors) of diseases, and significant benefits of prefilled syringes over traditional ampoule and syringe packaging system.
Moreover, with the emergence of advanced syringe features such as safety prefilled syringes with dual and customized chambers for delivery of lyophilized biological drugs, there has been an increase in the overall demand for prefilled syringes.
Although the glass prefilled syringes is currently dominating the market, the plastic prefilled syringes will take over this market position in the near future with increased advantages that plastic provides over glass such as prevention of overfill requirement, ease of handling, easy storage and shipping, time saving in emergency situation, free from leachable & extractable impurities, compatibility with a wide range of pH, and environment friendly disposal.
Acceptance of easy to use wearable and portable light therapy devices free from any side-effects or complications. The medical devices segment, especially the wearable devices was the fastest growing segment in 2016. This is due to the fact that wearable devices are versatile in nature (in terms of applicability and portability) and are preferred by most of the athletes. The medical devices is expected to witness a growth rate of 11.9% during the forecast period from 2017 to 2023, owing to their advancements within the basic design, thereby, offering a wide range of options for various end-user groups. Moreover, products such as Neuroon and Re-Timer also demonstrate an impressive growth and are expected to continue growing in the future, with increasing prevalence chronic diseases in developed countries such as the U.S. and Japan.
According to the report titled “Global Prefilled Syringes Market” put forward by the market research experts of BIS Research, the global prefilled syringes market is expected to grow over $XX million by 2023 at a CAGR of XX%. Large scale growth in injectable drug market and continuous technological advancement in prefilled syringes are some of the major factors driving this market. Furthermore, business expansion in emerging markets such as China, Brazil, India, Australia and Japan are also leading towards a number of opportunities for the global prefilled syringes market. As per the industry experts, around 56% of the total prefilled syringes used in Japan are plastic based. Furthermore, in high growth economies such as China and India, the markets for prefilled syringes are highly untapped and present lucrative growth opportunities mainly in terms of manufacturing of syringes.
The XX pages report with over XX market figures is a compilation of the different peripherals. This research study includes an extensive analysis of the global prefilled syringes market, by product type, material, design and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key participants. Some of the leading companies in the market are Gerresheimer AG, Becton Dickinson & Co., Stevanato Group, Baxter International, Inc., Unilife Corporation, Terumo Corporation, West Pharmaceuticals, Inc., and Vetter Pharmaceuticals.
The new range of companies are striving hard to file patents and get approvals from regulatory bodies in this growing market and launch innovative products, while established companies are busy in acquiring companies and partnerships with other ecosystem players. The increasing demand for safety plastic prefilled syringes due to its convenience and cost effectiveness have obligated companies to focus on new product developments and innovations. The most prominent opportunity for the industry players is market penetration in emerging markets such as Japan, China, Australia and India. Currently, the market is dominated by Europe due to the presence of established prefilled syringe and biological drug manufacturers based in Europe. However, stringent regulatory standards regarding combination products and high manufacturing cost of prefilled syringes are hampering the growth of the market. Market penetration, establishment and outreach of major key players in the emerging markets, and increasing biologics and bio-similar in the market will serve as viable opportunities for the market players to enhance their business in the future.
The market for prefilled syringes is expected to record growth during the forecast period mainly due to advantages offered by prefilled syringes over conventional vial and ampoule packaging systems, boost in the market for biologics and increasing preference for self-administration. Depending on the material used to manufacture the syringe barrel, prefilled syringes have been categorized into two major segments namely glass prefilled syringes and plastic prefilled syringes. Of these, in 2012, glass prefilled syringes accounted for the larger share of the total market both by revenue (94.3%) as well as volume (95.7%), and plastic prefilled syringes have a low market penetration globally. This is because glass is considered as the gold standard in syringe manufacturing since it is chemically inert, strong, and transparent and has high tolerability against heat. However, the market for plastic prefilled syringes is expected to record higher growth at a CAGR of 25% (by revenue) and 26% (by volume) during the forecast period owing to various advantages including resistance to breakage, lighter in weight, low leachability and hence, low threat of drug contamination.
Geographically, Europe was the largest regional market in 2012, both in terms of revenue as well as volume. The European market for prefilled syringes was valued at USD 911.5 million in 2012, with a volume consumption of 1,269.6 million units. During the forecast period, North America has been predicted to be the fastest growing regional market with an expected CAGR of 15.0% (by revenue) and 15.7% (by volume). The relatively untapped market of North America for prefilled syringes, presence of a large number of leading drug manufacturers in the region and the emergence of new syringe manufacturers will be responsible for this growth. The growing interest of syringe manufacturers in emerging markets such as India, China, Brazil, Mexico, Russia and South Africa is expected to drive growth of the prefilled syringes market in Asia-Pacific and Rest of the World (RoW).
The global market for prefilled syringes is highly consolidated and dominated by a few key players namely Becton, Dickinson & Company, Gerresheimer AG, Nipro Corporation, Schott AG and Stevanato Group. These players collectively accounted for an 89.8% share in terms of revenue of the total market in 2012. Becton, Dickinson & Company alone accounted for a 54.6% revenue share of the total market indicating its global leadership in the prefilled syringes market. Other notable players operating in this market comprise Unilife Corporation, Baxter International, Inc., Bespak, West Pharmaceutical Services, Inc., Ypsomed Holding AG and Vetter Pharma International GmbH.
Becton Dickinson & Company
Bristol Myers Squibb
Eli Lilly
Gerresheimer
Medtronic Inc.
Nipro Corporation
Pfizer
SCHOTT AG
Stevanto Group
Terumo Corporation
Unilife Corporation
Vetter Pharmaceuticals GmBH
Weigao Group
West Pharmaceutical Services
Baxter International
“Global Prefilled Syringes Market Anticipated to Grow over $XX Million by 2023”